000079004 001__ 79004
000079004 005__ 20220120225832.0
000079004 0247_ $$2doi$$a10.1371/journal.pone.0214252
000079004 0248_ $$2sideral$$a111471
000079004 037__ $$aART-2019-111471
000079004 041__ $$aeng
000079004 100__ $$aMartínez-Vispo, C.
000079004 245__ $$aCognitive-behavioral treatment with behavioral activation for smoking cessation: Randomized controlled trial
000079004 260__ $$c2019
000079004 5060_ $$aAccess copy available to the general public$$fUnrestricted
000079004 5203_ $$aIntroduction: Behavioral Activation is a behavioral-based treatment that has been proposed as suitable for smoking cessation, as it simultaneously addresses reinforcement-related variables and also mood management. The aim of this study was to compare the effects of a cognitivebehavioral smoking cessation treatment with components of behavioral activation (SCBSCT-BA) with a standard cognitive-behavioral treatment (SCBSCT), and a wait-list control group (WL).
Method: The sample was comprised of 275 adults smokers (61.4% females, mean age = 45.36, SD = 10.96). After baseline assessment sessions, participants were randomized (ratio: 2.2.1.) to SCBSCT-BA, SCBSCT, or WL. Active groups received 8 weekly 1-hour face-to-face group sessions. Biochemically verified smoking abstinence and depressive symptoms were assessed at the end of treatment, and at 3-, 6-, and 12-month follow-ups.
Results: Significant treatment effects in 7-dayspoint prevalence abstinence rates were found for both active groups at the end of treatment. Abstinence rates at 12-months follow-up were 30% for SCBSCT-BA, and 18% for SCBSCT. Using Multiple Imputation for missing data, regression analysis showed significantly greater ORs for the SCBSCT-BA condition (vs. SCBSCT) at the end of treatment and at 3-months follow-up. At 6-, and 12-months follow-ups, ORs for the SCBSCT-BA condition, although greater, did not reach statistical significance. Multilevel analysis showed that abstinence was related to reductions in depressive symptoms.
Conclusions: SCBSCT-BA obtained positive results at short and medium term. Participants who quit smoking experienced a significant reduction in depressive symptoms. Findings support the benefit of adding BA to a cognitive-behavioral smoking cessation treatment. Trial registration www.clinicaltrials.gov NCT02844595.
000079004 536__ $$9info:eu-repo/grantAgreement/ES/MINECO-FEDER/PSI2015-66755-R
000079004 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000079004 590__ $$a2.74$$b2019
000079004 591__ $$aMULTIDISCIPLINARY SCIENCES$$b27 / 71 = 0.38$$c2019$$dQ2$$eT2
000079004 592__ $$a1.023$$b2019
000079004 593__ $$aMultidisciplinary$$c2019$$dQ1
000079004 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000079004 700__ $$aRodríguez-Cano, R.
000079004 700__ $$aLópez-Durán, A.
000079004 700__ $$aSenra, C.
000079004 700__ $$0(orcid)0000-0002-9645-8109$$aFernández Del Río, E.$$uUniversidad de Zaragoza
000079004 700__ $$aBecoña, E.
000079004 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000079004 773__ $$g14, 4 (2019), e0214252[20 pp]$$pPLoS One$$tPLoS ONE$$x1932-6203
000079004 8564_ $$s816420$$uhttps://zaguan.unizar.es/record/79004/files/texto_completo.pdf$$yVersión publicada
000079004 8564_ $$s91235$$uhttps://zaguan.unizar.es/record/79004/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000079004 909CO $$ooai:zaguan.unizar.es:79004$$particulos$$pdriver
000079004 951__ $$a2022-01-20-22:55:24
000079004 980__ $$aARTICLE